藥易購(300937.SZ):子公司設立四川蜀坦人工智能科技有限公司
格隆匯8月5日丨藥易購(300937.SZ)公佈,公司全資子公司四川藥易購科技集團有限公司(以下簡稱“藥易購科技集團”)、杭州扶搖數智科技有限公司(簡稱“杭州扶搖”)共同投資設立四川蜀坦人工智能科技有限公司(以下簡稱“蜀坦人工智能”),註冊資本1,000萬元,資金來源為藥易購科技集團、杭州扶搖自有資金。公司通過下屬子公司持有蜀坦人工智能100%股權,蜀坦人工智能已於近日完成工商註冊登記,並取得成都市金牛區政務服務管理和行政審批局頒發的《營業執照》。
為響應數字經濟發展相關政策號召,公司致力基於AI數字智能化體系,搭建協同開放、多元賦能的數字化產業生態平台。公司本次投資設立的全資子公司蜀坦人工智能將依託當地政府的資源協同,整合數字化供應鏈、智能採銷體系、供應鏈金融等數據資源,運用人工智能、大數據、大模型、物聯網、雲計算等前沿技術搭建形成SaaS數字綜合服務平台,開展涵蓋行業上下游基礎數據、雲倉數字供應鏈、生產企業全網流向追溯體系等數據資源運營技術研發和場景應用推廣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.